ArticleTherapeutic advances in drug safety2024

A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS).

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.